Spire Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
4,384
-300
-6% -$103K 0.05% 312
2026
Q1
$1.65M Buy
4,684
+240
+5% +$85.6K 0.06% 298
2025
Q4
$1.45M Buy
4,444
+1,044
+31% +$331K 0.05% 324
2025
Q3
$959K Buy
3,400
+106
+3% +$30.7K 0.03% 384
2025
Q2
$920K Sell
3,294
-15,051
-82% -$4.26M 0.03% 378
2025
Q1
$5.72M Buy
18,345
+13,093
+249% +$3.87M 0.18% 110
2024
Q4
$1.37M Sell
5,252
-253
-5% -$75.1K 0.04% 323
2024
Q3
$1.77M Sell
5,505
-479
-8% -$157K 0.06% 258
2024
Q2
$1.87M Sell
5,984
-1,557
-21% -$457K 0.07% 242
2024
Q1
$2.14M Sell
7,541
-125
-2% -$36.6K 0.04% 242
2023
Q4
$2.36M Buy
7,666
+1,097
+17% +$299K 0.08% 213
2023
Q3
$1.77M Sell
6,569
-90
-1% -$22.5K 0.07% 239
2023
Q2
$1.48M Sell
6,659
-1,465
-18% -$340K 0.05% 271
2023
Q1
$1.96M Buy
8,124
+2,457
+43% +$603K 0.08% 232
2022
Q4
$1.49M Buy
5,667
+772
+16% +$207K 0.08% 192
2022
Q3
$1.1M Sell
4,895
-6,793
-58% -$1.65M 0.07% 202
2022
Q2
$2.84M Sell
11,688
-3,500
-23% -$858K 0.12% 163
2022
Q1
$3.67M Sell
15,188
-6,694
-31% -$1.54M 0.1% 190
2021
Q4
$4.92M Buy
21,882
+6,027
+38% +$1.27M 0.11% 176
2021
Q3
$3.37M Sell
15,855
-1,703
-10% -$392K 0.09% 203
2021
Q2
$4.28M Sell
17,558
-5,272
-23% -$1.3M 0.12% 176
2021
Q1
$5.29M Buy
+22,830
New +$5.45M 0.14% 155

Other funds holding AMGN

Spire Wealth Management's AMGN Position: Q2 2026 in Review

Spire Wealth Management reduced its Amgen (AMGN) stake by 6.4% in Q2 2026, selling an estimated $103K and leaving 4,384 shares worth $1.59M. The position accounts for 0.05% of the portfolio, ranked #312.

Spire Wealth Management first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.72M in Q1 2025. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Spire Wealth Management held 4,384 shares of Amgen worth $1.59M as of Q2 2026.
  • Spire Wealth Management sold 300 Amgen shares in Q2 2026, an estimated $103K.
  • Amgen made up 0.05% of Spire Wealth Management's portfolio in Q2 2026, its #312 holding.
  • Spire Wealth Management first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Amgen position peaked at $5.72M in Q1 2025.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.